Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net cash provided by operating activities | 25,680 | 35,459 |
| Investing activities: | ||
| Acquisition of GQ Bio Therapeutics GmbH (net of cash acquired) | (335) | (16,702) |
| Purchases of fixed assets | (2,724) | (8,548) |
| Purchases of available-for-sale investments | — | (69,629) |
| Sales of available-for-sale investments | 22,500 | 69,250 |
| Net cash provided by (used in) investing activities | 19,441 | (25,629) |
| Financing activities: |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Pacira BioSciences, Inc.'s capex?
- Pacira BioSciences, Inc. (PCRX) reported capex of $2.72M in Q1 2026.
- How has Pacira BioSciences, Inc.'s capex changed year-over-year?
- Pacira BioSciences, Inc.'s capex decreased by 68.1% year-over-year, from $8.55M to $2.72M.
- What is the long-term trend for Pacira BioSciences, Inc.'s capex?
- Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s capex has grown at a -24.0% compound annual growth rate (CAGR), from $45.87M to $15.33M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Pacira BioSciences, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude